Vantage Point Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vantage Point Financial's LLY Position: Q2 2026 in Review
Vantage Point Financial increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $43.9K and bringing the position to 1,216 shares worth $1.46M. The position accounts for 0.44% of the portfolio, ranked #45.
Vantage Point Financial first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vantage Point Financial held 1,216 shares of Eli Lilly worth $1.46M as of Q2 2026.
- Vantage Point Financial bought 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
- Eli Lilly made up 0.44% of Vantage Point Financial's portfolio in Q2 2026, its #45 holding.
- Vantage Point Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vantage Point Financial's 13F filing for Q2 2026, filed 14 Aug 2026.